Implant Sciences Corporation (NYSE Alternext US: IMX), a high
technology supplier of sophisticated systems and sensors for the
homeland security market and related industries, today announced the
award of a thirteen (13) month, $750,000 Phase II Small Business
Innovation Research ("SBIR”)
contract by the Department of Homeland Security ("DHS”),
Science & Technology Directorate in Washington, DC for the delivery of a
handheld trace explosives sampler (the "Handheld
Sampler”). Development of the Company’s
Handheld Sampler technology began earlier this year with the assistance
of a previously funded Phase I SBIR contract. The Phase II contract
calls for the Company to incorporate this technology into a prototype to
be delivered to DHS.
The Company plans to use its proprietary vortex collection technology in
this Handheld Sampler to augment the process of collecting samples used
in detecting and identifying a range of explosives materials. The
contract will be administered by the Department of Interior ("DOI”)
Acquisition Services Directorate, National Business Center.
Phillip C. Thomas, President and CEO of Implant Sciences, stated, "We
are pleased to continue working in partnership with the DOI and DHS in
advancing our Handheld Sampler technology. This effort is expected to
culminate with the introduction of a new innovative explosives detection
product for the security marketplace. We believe the use of a compact,
lightweight handheld sampler, incorporating our proprietary vortex
collection technology, could significantly improve explosives detection
capabilities while also being very user friendly. This non-contact
method could prove to be much more effective than traditional contact
sample collection, and at a much lower cost to users. This improved
sampling process has applicability for use in detecting trace amounts of
explosives found on a wide range of objects such as carry-on luggage,
parcels, packages and cargo. In addition, multiple handheld sampling
units could be systematically deployed in concert with a centralized
trace explosives detection system to improve efficiency and increase the
volume of articles screened. We think this product could usher in a new
way of thinking about how cargo and other items can be properly examined
in a cost effective and user friendly manner. It is with this objective
in mind that we anticipate the introduction of our first air cargo
screening system, which will utilize our Handheld Sampler technology, at
the AVSEC 2008 exhibition in Seoul, South Korea later this year.”
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors
and systems for the Security, Safety and Defense (SS&D) industries. The
Company has developed proprietary technologies used in its commercial
portable and bench-top explosive trace detection systems which ship to a
growing number of locations domestically and internationally. For
further details on the Company and its products, please visit the Company’s
website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements,” as that term is defined in the
Private Securities Litigation Reform Act of 1995. Such statements are
based on management’s current expectations
and are subject to risks and uncertainties that could cause the Company’s
actual results to differ materially from the forward-looking statements.
Such risks and uncertainties include, but are not limited to, the Company’s
ability to successfully integrate its handheld sampler technology into a
prototype, delivery of a handheld sampler prototype to DHS,
commercialization of a prototype handheld sampler, market acceptance of
a commercially available handheld sampler, and are subject to risks and
uncertainties that could cause the Company’s
actual results to differ materially from the forward-looking statements.
Such risks and uncertainties are described in the Company’s
filings with the Securities and Exchange Commission, including its most
recent Forms 10-K, 10-Q and 8-K.
For further information, you are encouraged to review Implant Sciences’
filings with the Securities and Exchange Commission, including its
Annual Report on Form 10-K for the period ended June 30, 2007 and
Quarterly Reports on Form 10-Q for the periods ended September 30, 2007,
December 31, 2007 and March 31, 2008. The Company assumes no obligation
to update the information contained in this press release.
